Drug Database
Back to search

Japan· JP-1124002M2022

フルラゼパム塩酸塩

A flurazepam product containing フルラゼパム塩酸塩, registered in Japan by 共和薬品工業, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

On Japan’s NHI price listATC N05CD01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedフルラゼパム塩酸塩ATCN05CD01REGISTER NO.JP-1124002M2022PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about フルラゼパム塩酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Flurazepam is registered in 11 of 19 countries.

Countries holding a registration under ATC N05CD01 (flurazepam), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 5 of them publish a price we can compare per daily dose
Search flurazepam products by name

Flurazepam · ATC N05CD01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flurazepam costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.14 in Spain to $1.13 in Switzerland — a ×7.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Flurazepam · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.13
  • ES Spain$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
フルラゼパム塩酸塩
Manufacturer
共和薬品工業
Country
Japan (JP)
ATC code
N05CD01
ATC class
Flurazepam
Defined daily dose
30 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

209 interactions on record for flurazepam.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check flurazepam against other medicinesHow interaction checks work

Flurazepam · interactions on record

209 records

  • 4 severe
  • 107 moderate
  • 22 minor
  • 32 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

44 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flurazepam in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flurazepam products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Belgium · Staurodorm
  • Germany · Flurazepam Real, Staurodorm Neu
  • Portugal · Morfex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f877762e-3ee1-4c5a-8368-f31eef308540
GET /v1/drugs/f877762e-3ee1-4c5a-8368-f31eef308540?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１５ｍｇ１カプセル",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1124002M2022",
  "category": "内用薬",
  "price_yen": 6.3,
  "generic_name": "フルラゼパム塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "1124",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about flurazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console